Connected scales for blood cancer patients at home
Part of Blood & lymphatic, Cancer, Heart & circulation, Immune system & allergy clinical trials.
This trial tests if using a connected scale to monitor your weight at home can help your doctors manage your treatment for aggressive non-Hodgkin's lymphoma or multiple myeloma. It may also apply if you need a stem cell transplant (autograft) for these conditions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older
- You have aggressive non-Hodgkin's lymphoma or multiple myeloma and are about to start or have already started up to 2 cycles of chemotherapy, or you need a stem cell transplant (autograft) for these diseases
- You can be reached by phone during the study
- You are able to go home after your first hospital stay
- You are covered by French social security
- You can read and speak French
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a connected scale can help monitor your weight over time after gastric bypass or sleeve surgery. It may help your care team spot changes earlier, by sending weight information from your home.
This study tests a digital tool to help doctors keep an eye on patients with chronic myeloid leukemia who have stopped their treatment. If you join, you'll use the tool to share health updates, which might help you stay safely off treatment.
This study uses wearable technology (like smartwatches) to monitor your health and quality of life while you receive treatment for blood cancers like myeloma or myelodysplastic syndromes. The goal is to help doctors better understand how blood transfusions and other supportive care affect how you feel day-to-day.
This study uses your self-reported symptoms (PRO) and wearable/device data to help improve care for people with relapsed multiple myeloma who are starting new treatment. It may help by providing insights about how you’re doing during therapy—without changing your cancer treatment in a study-specific way.
This study uses a smartphone or web app to track infections and quality of life in people with multiple myeloma or chronic lymphocytic leukemia who have a weakened immune system. The goal is to create a better screening tool for infections and understand how the disease and treatment affect daily life.
This trial looks at how well patient-recorded measurements can be used during cancer care around the time of curative-intent surgery or chemotherapy before surgery. It may help improve monitoring and decision-making during treatment.
Hear when a new Lymphoma, Non-Hodgkin trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.